期刊文献+

肺基底细胞样大细胞癌的临床病理学分析

Clinicopathologic Analysis of Lung Basaloid Large Cell Carcinoma
下载PDF
导出
摘要 目的分析肺基底细胞样大细胞癌(BLCC)的临床病理学特征。方法对2012年全年病理确诊的9例BLCC患者的临床病理学资料进行回顾性分析,并通过免疫组化方法检测HCK、P63、Syn、CgA、TTF-1等指标的表达情况。结果 9例BLCC占同期肺大细胞癌(LCC)的10.8%,占同期肺癌的0.6%。其中,男性8例,女性1例;平均年龄66.8岁;肿瘤最大径平均5.3 cm;影像学多表现为中央型。术前通过痰脱落细胞学、纤维支气管镜活检和肺穿刺活检三种手段,无1例确诊。9例患者均行手术切除。术后组织病理学9例均得以确诊,其中1例BLCC合并浸润性腺癌,3例发生淋巴结转移。结论 BLCC发病率低,是一种高度侵袭性的恶性肿瘤。BLCC的临床表现无特异性,确诊依靠病理学诊断。充分掌握BLCC独特的病理形态学特点和免疫组化表达特点,可显著提高BLCC的确诊率。 Objective To analyze and summarize the clinicopathologic characteristics of lung basaloid large cell carcinoma (BLCC). Methods Clinieopathologie data of 9 cases with BLCC eonfirmed by pathology in 2012 were retrospectively reviewed. Expression of HCK, P63, Syn, CgA, CKT, CK5/6 and TTF-1 were detected by immunohistochemisty method. Results 9 cases of BLCC accounted for 10.8% of lung large cell carcinoma (LCC) and 0.6% of lung cancer. 8 cases were male, 1 female, the average age is 66.8 years old. Average maximum diameter of the tumor was 5.3 cm. Central type was common manifestations in imageology. Sputum exfoliocytology, biopsy of bronchofibroscope and paracentesis were adopted before surgery, whereas none of BLCC were diagnosed. 9 cases underwent surgical resection. Postoperative pathology diagnosis indicated that 9 cases were BLCC, l case was combined with adenocarcinoma infiltrating. Lymph node metastasis occured in 3 cases. Conclusion Incidence rate of BLCC is low and BLCC is a highly aggressive malignancy. Clinical manifestation of BLCC do not have specificity and final diagnosis of BLCC depends on pathology diagnosis. Diagnosis rate of BLCC will be significantly improved, only if unique pathomorphology and immunohistochemical expression characteristics are thoroughly mastered.
出处 《透析与人工器官》 2013年第4期6-10,共5页 Chinese Journal of Dialysis and Artificial Organs
关键词 基底细胞样癌 大细胞癌 肺肿瘤 病理学 回顾性分析 basaloid carcinoma large cell carcinoma lung tumor pathology retrospective analysis
  • 相关文献

参考文献8

  • 1Travis WD,孟宇宏,张建中,译.肺、胸膜、胸腺及心脏肿瘤病理学和遗传学(WHO肿瘤分类及诊断标准系列)[M].北京:人民卫生出版社,2006:44-52.
  • 2Brambilla E, Moro D, Veale D, et al. Basal cell (basaloid) carci- noma of the lung: a new morphologic and phenolypic entity with separate prognostic significance[J]. Human Pathology, 1992,23 (9):993-1003.
  • 3Moro-Sibilot D, Lantuejoul S, Diab S, et al. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis [J]. The European Respiratory Journal, 2008,31(4):854-859.
  • 4姚楚云,陈春梅.肺的基底细胞样癌[J].肿瘤防治研究,1996,23(1):14-15. 被引量:2
  • 5张静,于津浦,熊艳娟,曹杉,曹水,任秀宝.大细胞肺癌患者预后影响因素及术后CIK治疗疗效的分析[J].中国肿瘤生物治疗杂志,2011,18(6):663-667. 被引量:2
  • 6Saji H,Tsubli M, Matsubayashi J,et al. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy [J]. Anticancer Drugs, 2010,21 (1): 89-93.
  • 7Yamada S, Noguchi H, Nabeshima A, et al. Basaloid carcinoma of the lung associated with central cavitation: a unique surgical case focusing on cytological and immunohistochemical findings [J]. Diagnostic Pathology, 2012,7:175-180.
  • 8Crapanzano JP, Loukeris K, Borczuk AC, et al. Cytological, his- tological and immunohistochemical findings of pulmonary car- cinomas with basaloid features[J]. Diagnostic Cytopathology, 2011,39(2):92-100.

二级参考文献20

  • 1李香丹,孙抒,宋莲莲,杨万山,金铁峰.CIK细胞对乳腺癌细胞株ZK-75-1的杀伤作用及其机制[J].细胞与分子免疫学杂志,2006,22(3):314-317. 被引量:9
  • 2Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors [ J ]. Semin Roentgenol, 2005, 40 (2) : 90-97.
  • 3Hanagiri T, Oka S, Takenaka S, et al. Results of surgical resec- tion for patients with large cell carcinoma of the lung [ J ]. Int J Surg, 2010, 8(5): 391-394.
  • 4Battafarano RJ, Fernandez FG, Ritter J, et al. Large cell neuro- endocrine carcinoma: An aggressive form of non-small cell lung cancer [J]. J Thorae Cardiovase Surg, 2005, 130 (1): 166- 172.
  • 5Saji H, Tsuboi M, Matsubayashi J, et al. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative ad- juvant chemotherapy [J]. Anticancer Drugs, 2010, 21 (1) : 89- 93.
  • 6Yamazaki S, Sekine I, Matsuno Y, et al. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy [J]. Lung Cancer, 2005, 49(2): 217-223.
  • 7Veronesi G, Morandi U, Alloisio M, et al. Large cell neuroendo- crine carcinoma of the lung: A retrospective analysis of 144 surgi- cal cases [J]. Lung Cancer, 2006, 53(1) : 111-115.
  • 8Rossi G, Cavazza A, Marchioni A, et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbe- ta, and Met in large-cell neuroendocrine carcinoma of the lung [J]. J Clin Oneol, 2005, 23(34) : 8774-8785.
  • 9Iyoda A, Hiroshima K, Toyozaki T, et al. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features [ J ]. Cancer, 2001, 92(5) : 1108-1112.
  • 10Paci M, Cavazza A, Annessi V, et al. Large cell neuroendocrine carcinoma of the lung: A 10-year clinicopathologic retrospective study [J]. Ann Thorac Surg, 2004, 77(4) : 1163-1167.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部